early esophageal cancer
Conditions
Interventions
Applying 2 vials of Kenacort(50mg/5ml/V) with endolubri jelly(7.5ml) on the day of endoscopic mucosal dissection(postoperative Day 5,Day 8,Day12,Day15,Day20)
Sponsors
Kagawa university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with early esophageal cancer scheduled for endoscopic submucosal dissection from whom informed consent was obtained
Exclusion criteria
Exclusion criteria: Post operative esophagus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured stenosis area by using esophagography at the right anterior oblique position | — |
Countries
Japan
Outcome results
None listed